● Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: third agent study. Diabetes Res Clin Pract. 2023 Aug 11;110872. doi: 10.1016/j.diabres.2023.110872. Online ahead of print. ● Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi-heart study. Diabetes Obes Metab. 2023 Aug;25(8):2181-2190. doi: 10.1111/dom.15095. Epub 2023 May 3. ● A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain. Medicine (Baltimore). 2023 Apr 25;102(17):e33701. ● Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr. 2023 Mar 30;32(1):1-24. doi: 10.7570/jomes23016. Epub 2023 Mar 22. ● Effects of Virtual Reality Exercise Program on Blood Glucose, Body Composition, and Exercise Immersion in Patients with Type 2 Diabetes. Int. J. Environ. Res. Public Health 2023, 20(5), 4178 ● Factors Associated with Body Weight Gain among Korean Adults during the COVID-19 Pandemic. J Obes Metab Syndr. 2022 Mar 30;31(1):51-60. doi: 10.7570/jomes21087. ●Extent of Role: Anti-Diabetic Medications. J Korean Diabetes 2022;23:153-156 ● SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease: Trends Endocrinol Metab . 2022 Jun;33(6):424-442. doi: 10.1016/j.tem.2022.03.005. Epub 2022 Apr 28. ● A paradigm shift in dyslipidemia management in primary care: a 12-month cohort study, (2022: Clinical Therapeutics, Published:April 08, 2022DOI:https://doi.org/10.1016/j.clinthera.2022.03.004) ● Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis. ( J Clin Endocrinol Metab. 2021 Jul 24;dgab539.) ● Diabetes and Vitamin D. (J Korean Diabetes. 2021;22(1):6-11.) ● Deterioration of sleep quality according to glycemic status. (Diabetes Metab J 2020 Oct;44(5):679-686.) ● A Comparison Study on Efficacy, Insulin Sensitivity and Safety of Glimepiride/Metformin Fixed Dose Combination Versus Glimepiride Single Therapy on Type 2 Diabetes Mellitus Patients With Basal Insulin Therapy (Diabetes Res Clin Pract . 2019 Sep;155:107796) ● Prevention of Major Adverse Cardiovascular and Renal Outcomes with Sodium-Glucose Cotransporter 2 Inhibitors (J Korean Diabetes 2019;20:87-91) ● Effects of aromatherapy on stress, fructosamine, fatigue, and sleep quality in prediabetic middle-aged women: A randomised controlled trial (Eur J Int M 2019 Volume 31, October 2019, 100979) ● Letter: The Necessity of the Simple Tests for Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus Patients without Neuropathic Symptom in Clinical Practice (Diabetes Metab J 2018;42:442-6). [Diabetes Metab J. 2018] ● Paradigm shift in the management of type B insulin resistance. [Annals of Translational M. 2018] ● Patient Understanding of Hypoglycemia in Tertiary Referral Centers. [Diabetes Metab J. 2018] ● PDE 5 inhibitor improves insulin sensitivity by enhancing mitochondrial function in adipocytes. [Biochem Biophys Res Commun. 2017] ● Implications of Oncocytic Change in Papillary Thyroid Cancer.[Clinical Endocrinology. 2016] ● Colorectal cancer-derived tumor spheroids retain the characteristics of original tumors [Cancer Lett. 2015] ● Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment [Diabetes Res Clin Pract. 2015] ● GDF15 Is a Novel Biomarker for Impaired Fasting Glucose [Diabetes Metab J. 2014] ● A Novel PHEX Gene Mutation in a Patient with Sporadic Hypophosphatemic Rickets [Endocrinol Metab (Seoul). 2014] ● Two weeks aroma inhalation effects on blood pressure in young men with essential hypertension [European Journal of Integrative Medicine 2013] ● Urinary chiro- and myo-inositol levels as a biological marker for type 2 diabetes mellitus [Dis Markers. 2012]